In humans, several clinical case reports document that the combination of local irradiation and anti-CTLA-4 (iplimumab) in patients with melanoma [164], or NSCLC [165], can result in regression not only of irradiated but also of distant lesions in melanoma and lung cancer patients, also known as the abscopal effect. Here, CTLA4 is linked to lung carcinoma.